Ascend Wellness Holdings (AAWH) Total Debt (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Total Debt of $302.1 million for Q1 2026, down 9.29% year-over-year from $333.0 million in Q1 2025, and down 8.43% quarter-over-quarter from $329.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Debt (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Debt history runs 7 years deep, the most recent figure standing at $302.1 million for Q1 2026.
- In Q1 2026, Total Debt fell 9.29% year-over-year to $302.1 million; the TTM figure through Mar 2026 stood at $302.1 million (down 9.29% YoY), while the FY2025 annual figure was $329.9 million, down 13.35% from the prior year.
- Total Debt for Q1 2026 stood at $302.1 million, down from $329.9 million in the prior quarter.
- The five-year high for Total Debt was $380.7 million in Q4 2024, with the low at $233.7 million in Q1 2022.
- The 5-year median for Total Debt is $310.4 million (2022), against an average of $317.9 million.
- The sharpest annual moves came in 2022 and 2025: Total Debt jumped 127.73% in 2022, then retreated 13.35% in 2025.
- Ascend Wellness Holdings' Total Debt stood at $330.6 million in 2022, then decreased by 7.55% to $305.7 million in 2023, then grew by 24.55% to $380.7 million in 2024, then retreated by 13.35% to $329.9 million in 2025, then decreased by 8.43% to $302.1 million in 2026.
- Business Quant data shows AAWH's Total Debt at $302.1 million in Q1 2026, $329.9 million in Q4 2025, and $369.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 760.00 Mn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 359.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 359.67 Mn |
| Mar 31, 2026 | 302.09 Mn |
| Dec 31, 2025 | 329.89 Mn |
| Sep 30, 2025 | 369.05 Mn |
| Jun 30, 2025 | 349.58 Mn |
| Mar 31, 2025 | 333.02 Mn |
| Dec 31, 2024 | 380.72 Mn |
| Sep 30, 2024 | 305.90 Mn |
| Jun 30, 2024 | 309.29 Mn |
| Mar 31, 2024 | 310.52 Mn |
| Dec 31, 2023 | 305.67 Mn |
| Sep 30, 2023 | 307.42 Mn |
| Jun 30, 2023 | 309.80 Mn |
| Mar 31, 2023 | 324.05 Mn |
| Dec 31, 2022 | 330.63 Mn |
| Sep 30, 2022 | 310.44 Mn |
| Jun 30, 2022 | 293.28 Mn |
| Mar 31, 2022 | 233.70 Mn |
| Dec 31, 2021 | 258.79 Mn |
| Sep 30, 2021 | 255.57 Mn |